Molecular mechanism of Ax subtype caused by p.M142I mutation in alpha 1-3-N-acetylgalactosaminyltransferase

doi:10.16150/j.1671-2870.2018.03.006

Abstract

Abstract: Objective: To explore the potential molecular mechanism of A_x subtypes in Chinese population based on an A_x subtype family. Methods: The ABO blood group serological tests and detection of the total plasma activity of alpha α-1,3-N-acetylgalactosaminyltransferase were conducted. ABO gene was sequenced directly and sequenced after cloning to construct 3D molecular model, and then the effect of identified mutation on protein stability changes (ΔΔG) of alpha α-1,3-N-acetylgalactosaminyltransferase was predicted. Results: The proband was diagnosed as A_xB subgroup byserological analysis, and AW.38/B.01 was identified by DNA analysis. His two daughters were identified as A and AB blood group, and their ABO genotypes were A1.02/B.01, A1.02/AW.38, respectively.There was a c.426G>C heterozygous mutation in ABO exon 7 of the proband and his A type daughter, leading to p.M142I change in the amino acid of α-1,3-N-acetylgalactosaminyltransferase. Molecular modeling and analysis suggested that the mutation may lead to changes in the number of hydrogen bonds formed. The increase of ΔΔG value of thermodynamic stability changes indicated that the protein stability was reduced. Conclusions: The mutation of p.M142I in α-1,3-N-acetylgalactosaminyltransferase may lead to A_x phenotype by reducing the stability of the enzyme. In vitro study is needed for further investigation.

Key words: ABO blood group, α-1, 3-N-acetylgalactosaminyltransferase, Gene mutation, Protein stability

CLC Number:

R446.11

WANG Dengfeng, CUI Wenyan, ZOU Wei, LI Fang, WANG Xuefeng, CAI Xiaohong. Molecular mechanism of A_x subtype caused by p.M142I mutation in alpha 1-3-N-acetylgalactosaminyltransferase[J]. Journal of Diagnostics Concepts & Practice, 2018, 17(03): 260-265.

References

[1] Yamamoto F, McNeill PD, Yamamoto M, et al. Molecular genetic analysis of the ABO blood group system: 3. A(X) and B(A) alleles[J]. Vox Sang,1993,64(3):171-174.
[2] Olsson ML, Chester MA. Heterogeneity of the blood group Ax allele: genetic recombination of common alleles can result in the Ax phenotype[J]. Transfus Med,1998 Sep,8(3):231-238.
[3] Ogasawara K, Yabe R, Uchikawa M, et al.Recombination and gene conversion-like events may contribute to ABO gene diversity causing various phenotypes[J]. Immunogenetics,2001,53(3):190-199.
[4] Olsson ML, Irshaid NM, Hosseini-Maaf B, et al.Genomic analysis of clinical samples with serologic ABO blood grouping discrepancies: identification of 15 novel A and B subgroup alleles[J]. Blood,2001,98(5):1585-1593.
[5] Seltsam A, Hallensleben M, Kollmann A, et al.The nature of diversity and diversification at the ABO locus[J]. Blood,2003,102(8):3035-3042.
[6] Deng ZH, Yu Q, Wu GG, et al.Molecular genetic analysis for Ax phenotype of the ABO blood group system in Chinese[J]. Vox Sang,2005 ,89(4):251-256.
[7] Cai X, Jin S, Liu X, et al.Molecular genetic analysis of ABO blood group variations reveals 29 novel ABO subgroup alleles[J]. Transfusion,2013,53(11 Suppl 2):2910-2916.
[8] Campbell AJ, Lamb ML, Joseph-McCarthy D.Ensemble-based docking using biased molecular dynamics[J]. J Chem Inf Model,2014,54(7):2127-2138.
[9] Cai XH, Jin S, Liu X, et al.Molecular genetic analysis for the B subgroup revealing two novel alleles in the ABO gene[J]. Transfusion,2008,48(11):2442-2447.
[10] Pettersen EF, Goddard TD, Huang CC, et al.UCSF Chimera--a visualization system for exploratory research and analysis[J]. J Comput Chem,2004,25(13):1605-1612.
[11] Reumers J, Schymkowitz J, Ferkinghoff-Borg J, et al.SNPeffect: a database mapping molecular phenotypic effects of human non-synonymous coding SNPs[J]. Nucleic Acids Res,2005,33:D527-D532.
[12] de Baets G, van Durme J, Reumers J, et al. SNPeffect 4.0: on-line prediction of molecular and structural effects of protein-coding variants[J]. Nucleic Acids Res,2012,40(Database issue):D935-D939.
[13] Guerois R, Nielsen JE, Serrano L.Predicting changes in the stability of proteins and protein complexes: a study of more than 1 000 mutations[J]. J Mol Biol, 2002,320(2):369-387.
[14] Yu Q, Deng ZH, Wu GG, et al.Molecular genetic analysis for a novel Ael allele of the ABO blood group system[J]. J Hum Genet, 2005, 50(12):671-673.
[15] Zhu F, Xu X, Hong X, et al.A 425T>C mutation in the B allele for the ABO transferase is associated with the B3 phenotype in Han Chinese persons[J]. Transfusion,2008, 48(11):2476-2477.
[16] DANIELS G.Human blood groups[M]. Oxford: Blackwell Scientific, Second edition, 2002.
[17] 蔡晓红, 金沙, 刘曦, 等. 中国人群ABO 亚型中一个新的A_x等位基因的鉴定[J]. 临床血液学杂志, 2009,22(6):309-312.
[18] Lee S Y, Ihm C, Shin D J, et al.The p.R168Q mutation is associated with the Bw phenotype and a predicted decrease in the stability of the resulting ABO glycosyltransferase[J]. Transfusion, 2013,54(5):1298-1304.
[19] Patenaude SI, Seto NO, Borisova SN, et al.The structural basis for specificity in human ABO(H) blood group biosynthesis[J]. Nat Struct Biol,2002,9(9):685-690.
[20] Cho D, Shin DJ, Yazer MH, et al.The M142T mutation causes B3 phenotype: three cases and an in vitro expression study[J]. Korean J Lab Med,2010,30(1):65-69.

Molecular mechanism of A_x subtype caused by p.M142I mutation in alpha 1-3-N-acetylgalactosaminyltransferase

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	HAO Xu, WANG Weiming. Fabry disease presenting with renal disease as the main manifestation diagnosed by renal biopsy: a case report [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(04): 527-529.
[2]	ZHOU Lu, LEI Hang, HONG Ye, JIN Shuang, DONG Yongqin, WANG Xuefeng, CAI Xiaohong. A_wB subtype caused by a novel ABO A* allele and its molecular mechanisms [J]. Journal of Diagnostics Concepts & Practice, 2021, 20(06): 547-551.
[3]	LEI Hang, FAN Liangfeng, CAI Xiaohong, WANG Yuqing, LIU Xi, JIN Sha, SHEN Wei, LU Qiong, XIANG Dong, WANG Xuefeng, ZOU Wei. The study on molecular basis of ABO blood subgroups in the Chinese population [J]. Journal of Diagnostics Concepts & Practice, 2020, 19(04): 364-369.
[4]	PENG Zhenping, XIANG Xixi, ZHANG Sujiang, LI Jiaming. Chronic neutrophilic leukemia with leukemia-like reaction as the first-onset manifestation: a report of 2 cases and literature review [J]. Journal of Diagnostics Concepts & Practice, 2020, 19(02): 122-128.
[5]	CAI Rong, MIN Xuewen, CHEN Meirong, SHEN Yating, SHI Qunli, ZHOU Xiaodie. Expression of BRAF V600E (VE1) in thyroid papillary carcinoma and its clinical significance [J]. Journal of Diagnostics Concepts & Practice, 2018, 17(05): 552-556.
[6]	LU Jing, XU Yufei, QING Yanrong, HAN Cong, LI Niu, YU Tingting, YAO Ruen, WANG Jian. Concurrent gene mutation analysis of a developmental delayed child with Rett syndrome and Noonan syndrome [J]. Journal of Diagnostics Concepts & Practice, 2018, 17(02): 147-150.
[7]	JIN Peipei, LIANG Qian, DAI Jing, DING Qiulan, SUN Shunchang, WANG Xuefeng. Phenotype and genotype analysis of a Chinese pedigree with 2N type von Willebrand disease [J]. Journal of Diagnostics Concepts & Practice, 2018, 17(02): 151-154.
[8]	WANG Shu, ZHANG Yunxiang, SUI Jingni, LU Jing, FAN Huiyong, WANG Chao, CHEN Bing.. Analysis of additional mutation pattern accompanied with CEBPA mutations in patients with the cytogenetically normal acute myeloid leukemia [J]. Journal of Diagnostics Concepts & Practice, 2017, 16(05): 498-503.
[9]	. [J]. Journal of Diagnostics Concepts & Practice, 2015, 14(06): 514-518.
[10]	. [J]. Journal of Diagnostics Concepts & Practice, 2015, 14(03): 235-238.
[11]	. [J]. Journal of Diagnostics Concepts & Practice, 2015, 14(01): 51-57.
[12]	. [J]. Journal of Diagnostics Concepts & Practice, 2014, 13(01): 44-48.
[13]	. [J]. Journal of Diagnostics Concepts & Practice, 2012, 11(03): 252-257.
[14]	. [J]. Journal of Diagnostics Concepts & Practice, 2009, 8(06): 631-634.
[15]	. [J]. Journal of Diagnostics Concepts & Practice, 2009, 8(03): 296-301.